EMBC
Embecta Corp. Healthcare - Medical Instruments & Supplies Investor Relations →
Embecta Corp. (EMBC) closed at $8.89 as of 2026-03-20, trading 47.0% below its 200-week moving average of $16.76. This places EMBC in the extreme value zone. The stock moved further from the line this week, up from -47.8% last week. The 14-week RSI sits at 31, indicating neutral momentum.
Trading volume is running at 1.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.14 ratio) is neutral — neither side is clearly dominating.
Over the past 160 weeks of data, EMBC has crossed below its 200-week moving average 1 time. On average, these episodes lasted 156 weeks.
With a market cap of $526 million, EMBC is a small-cap stock. The company generates a free cash flow yield of 35.9%, which is notably high. The stock trades at -0.9x book value.
Share count has increased 2.5% over three years, indicating dilution.
Over the past 3.2 years, a hypothetical investment of $100 in EMBC would have grown to $32, compared to $171 for the S&P 500. EMBC has returned -30.4% annualized vs 18.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -22.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EMBC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EMBC Crosses Below the Line?
Across 1 historical episodes, buying EMBC when it crossed below its 200-week moving average produced an average return of -51.0% after 12 months (median -51.0%), compared to +30.0% for the S&P 500 over the same periods. After 24 months, the average return was -54.0% vs +40.0% for the index.
Each line shows $100 invested at the moment EMBC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
EMBC has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2023 | Ongoing | 156+ | 56.4% | Ongoing | -64.2% |
Frequently Asked Questions
Is EMBC below its 200-week moving average?
Yes. As of 2026-03-20, Embecta Corp. (EMBC) is trading 47.0% below its 200-week moving average of $16.76. The current price is $8.89.
What is EMBC's 200-week moving average price?
Embecta Corp.'s 200-week moving average is $16.76 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EMBC drops below its 200-week moving average?
EMBC has crossed below its 200-week moving average 1 time in our data. These episodes lasted 156 weeks on average.
Is EMBC a good value right now?
Here's what our data says about EMBC as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 31. Free cash flow yield is 35.9%. Price-to-book is -0.9x. This is not a buy or sell recommendation — always do your own research.
How does EMBC compare to the S&P 500?
Over the past 3.2 years, $100 invested in EMBC would have grown to $32, compared to $171 for the S&P 500. That's -30.4% annualized vs 18.4% for the index. EMBC has underperformed the broader market over this period.
Does EMBC pay a dividend?
Yes. Embecta Corp. currently pays a dividend yield of 674.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20